The report highlights the company's commitment to creating value for patients living with severe diseases, employees, communities, and the planet. It includes the company's financial performance, key highlights, and sustainability efforts. The report focuses on specific and unique highlights of 2020, including the launch of the UCB Community Health Fund, the acquisition of Ra Pharmaceuticals and Engage Therapeutics, and the company's commitment to becoming carbon neutral by 2030.
Issuing Company UCB S.A.
Report Type Integrated Report
Report Language EN
Report Filesize 6.79 MB
No. of Pages 296 pages
Reporting periodJanuary 1, 2020-December 31, 2020
Report EditionUnknown
Assurance Provider a third party
Reporting Standards GRI; Global Reporting Standards
Materiality Assessmenttrue
